CRVL — CorVel Corporation stock price, charts and financials

QT41CorVel Corporation

CorVel Corporation (NASDAQ: CRVL) is a Financial Services company in the Insurance - Brokers industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
61.88
-0.68-1.08%
CRVLQT41CorVel Corporation·NASDAQ
61.88-1.08%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E27.80EPS (ttm)2.25Insider Own41.23%Shs Outstand51.01MPerf Week4.16%
Market Cap3.19BForward P/E35.95EPS next Y1.74Insider Trans-0.34%Shs Float30.93MPerf Month-0.33%
Enterprise Value2.96BPEG1.88EPS next Q-Inst Own-Short Float3.56%Perf Quarter7.75%
Income115.84MP/S3.24EPS this Y-18.69%Inst Trans-Short Ratio5.15Perf Half Y28.38%
Sales983.74MP/B7.77EPS next Y-ROA16.72%Short Interest1.10MPerf YTD-7.55%
Book/sh-P/C21.11EPS next 5Y-ROE29.93%52W High92.69 -33.24%Perf Year-29.18%
Cash/sh-P/FCF28.04EPS past 3/5Y19.31% -3.06%ROIC16.65%52W Low44.34 39.55%Perf 3Y-13.38%
Dividend Est.-EV/EBITDA16.88Sales past 3/5Y10.08% 11.64%Gross Margin24.79%Volatility4.90% 3.14%Perf 5Y33.28%
Dividend TTM-EV/Sales3.00EPS Y/Y TTM16.94%Oper. Margin10.82%ATR (14)2.30Perf 10Y310.77%
Dividend Ex-Date-Quick Ratio1.94Sales Y/Y TTM7.14%Profit Margin11.72%RSI (14)55.44Recom-
Dividend Gr. 3/5Y-Current Ratio1.94EPS Q/Q32.61%SMA202.41%Beta0.94Target Price-
Payout0.00%Debt/Eq0.05Sales Q/Q7.33%SMA502.46%Rel Volume0.67Prev Close62.56
Employees5,239LT Debt/Eq0.05EarningsNov 03SMA2000.83%Avg Volume216.03KPrice61.88
IPO DateJun 28, 1991Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA-1.34Volume145,083Change-1.08%
Latest News
Aug-05-26
Jul-27-26
Jul-21-26
Jul-17-26
Jul-08-26
Jun-17-26
Company

CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2026
3/31/2026
FY 2025
3/31/2025
FY 2024
3/31/2024
FY 2023
3/31/2023
FY 2022
3/31/2022
FY 2021
3/31/2021
FY 2020
3/31/2020
FY 2019
3/31/2019
Total Revenue985959896
Cost of Goods Sold Incl. D&A740726686
Gross Profit244233210
Selling, General and Administrative Excl. Other89,71289,73289
Research and Development
000
Other Operating Expense-89,620-89,6420
Operating Income107143121
Interest Expense
000
Unusual Expense
Non-Operating Income (Expense)
300
Net Income Before Taxes109143121
Income Taxes363326
Consolidated Net Income11511095
Net Income From Continuing Operations11511095
Net Income11511095
EPS (Recurring)2.252.151.85
EPS (Basic, Before Extraordinaries)2.252.151.85
EPS (Diluted)2.252.141.83
EBITDA175175150
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio27.5025.5461.19
Price To Sales Ratio3.202.916.37
Gross Margin24.7724.3023.44
Operating Margin10.8614.9113.50
Net Margin11.6811.4710.60
Shares Outstanding515151
Market Capitalization3,1562,7875,710
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$121.68$100.29$78.91$57.52$36.13 Close Price0.00M2.73M5.45M8.18M10.91MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Nichols Brian S.Chief Financial OfficerAug 04 '26Option Exercise52.65512,68556Aug 05
HOOPS ALANDirectorJul 31 '26Option Exercise14.449,000129,96033,192Aug 03
Bertels Mark E.EVP - Risk Management ServicesJul 29 '26Option Exercise52.6575039,4853,576Jul 30
Shishin MaximChief Information OfficerJun 12 '26Option Exercise52.652,250118,4569,300Jun 15
Combs Michael GCEO & PresidentJun 12 '26Sale60.7950030,39512,322Jun 15
Shishin MaximChief Information OfficerJun 12 '26Sale60.592,250136,3287,050Jun 15
JESSUP R JUDDDirectorJun 11 '26Option Exercise14.449,000129,960120,798Jun 12
Combs Michael GCEO & PresidentJun 11 '26Sale60.557,000423,82012,822Jun 11
Combs Michael GCEO & PresidentJun 10 '26Sale61.387,000429,62619,822Jun 11
Combs Michael GCEO & PresidentJun 09 '26Sale60.907,000426,29326,822Jun 11
MICHAEL JEFFREY Jdirector, 10 percent owner:Jun 09 '26Option Exercise14.449,000129,960568,721Jun 10
MICHAEL JEFFREY Jdirector, 10 percent owner:Jun 09 '26Sale60.989,000548,834559,721Jun 10
Combs Michael GCEO & PresidentJun 08 '26Sale60.227,000421,55833,822Jun 09
Yoss JenniferVice President of AccountingMay 26 '26Option Exercise50.931,999101,8123,131May 27
Yoss JenniferVice President of AccountingMay 26 '26Sale61.0290054,9182,173May 27
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.